Sep 19, 2024, 12:03
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X:
“Hot off the Press!
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer with or without Brain Metastases practice changing results from a phase 3b/4 trial.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 22:51
Dec 2, 2024, 22:47
Dec 2, 2024, 22:38
Dec 2, 2024, 22:36
Dec 2, 2024, 21:38
Dec 2, 2024, 20:23